Invitrogen Licenses Harvard's Click Chemistry Technology for Cell-Based Assays | GenomeWeb

NEW YORK (GenomeWeb News) - Invitrogen has licensed cell proliferation assay technology from Harvard University that it will use in its click chemistry technology-related programs, the company said today.

The company said it is adding the Harvard technology to its click chemistry IP portfolio, which includes a license from the Scripps Research Institute and agreements with the University of California, Berkeley, the California Institute of Technology, and the National Institutes of Health.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.